281 related articles for article (PubMed ID: 16724975)
1. New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome.
Pereira PM; Bines JE
J Gastroenterol Hepatol; 2006 Jun; 21(6):932-40. PubMed ID: 16724975
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor is critical for intestinal adaptation following small bowel resection.
Stern LE; Erwin CR; O'Brien DP; Huang F; Warner BW
Microsc Res Tech; 2000 Oct; 51(2):138-48. PubMed ID: 11054864
[TBL] [Abstract][Full Text] [Related]
3. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
5. Growth factors in short-bowel syndrome patients.
Jeppesen PB
Gastroenterol Clin North Am; 2007 Mar; 36(1):109-21, vii. PubMed ID: 17472878
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone, epidermal growth factor, and insulin on bacterial translocation in experimental short bowel syndrome.
Eizaguirre I; Aldazabal P; Barrena MJ; Garcia-Arenzana JM; Ariz C; Candelas S; Tovar JA
J Pediatr Surg; 2000 May; 35(5):692-5. PubMed ID: 10813326
[TBL] [Abstract][Full Text] [Related]
7. Short bowel syndrome: the role of GLP-2 on improving outcome.
Wallis K; Walters JR; Gabe S
Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):526-32. PubMed ID: 19474717
[TBL] [Abstract][Full Text] [Related]
8. Teduglutide for the treatment of short bowel syndrome.
Ferrone M; Scolapio JS
Ann Pharmacother; 2006 Jun; 40(6):1105-9. PubMed ID: 16705029
[TBL] [Abstract][Full Text] [Related]
9. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
Martin GR; Wallace LE; Hartmann B; Holst JJ; Demchyshyn L; Toney K; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G431-8. PubMed ID: 15388486
[TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin-11 and epidermal growth factor on residual small intestine after experimental massive small bowel resection.
Ledniczky G; Fiore N; Bognár G; Ondrejka P; Grosfeld JL
Chirurgia (Bucur); 2006; 101(2):127-33. PubMed ID: 16752677
[TBL] [Abstract][Full Text] [Related]
11. Peptide growth factors and intestinal adaptation in short bowel syndrome.
Sukhotnik I; Siplovich L; Krausz MM; Shiloni E
Isr Med Assoc J; 2003 Mar; 5(3):184-7. PubMed ID: 12725139
[TBL] [Abstract][Full Text] [Related]
12. Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?
Yazbeck R; Howarth GS; Abbott CA
Cytokine Growth Factor Rev; 2009 Apr; 20(2):175-84. PubMed ID: 19324585
[TBL] [Abstract][Full Text] [Related]
13. Effect of sex and sex hormones on structural intestinal adaptation after massive small bowel resection in rats.
Sukhotnik I; Shiloni E; Mogilner J; Lurie M; Hirsh M; Coran AG; Krausz MM
J Pediatr Surg; 2005 Mar; 40(3):489-95. PubMed ID: 15793723
[TBL] [Abstract][Full Text] [Related]
14. Overview of intestinal adaptation and its stimulation.
Robinson MK; Ziegler TR; Wilmore DW
Eur J Pediatr Surg; 1999 Aug; 9(4):200-6. PubMed ID: 10532257
[TBL] [Abstract][Full Text] [Related]
15. [Effect of various trophic factors on bacterial translocation in experimental short bowel syndrome].
Eizaguirre I; Aldazabal P; García N; Orgiles I; García-Arenzana JM; Ariz C; Tovar JA; Candelas S
Cir Pediatr; 2001 Jan; 14(1):4-8. PubMed ID: 11339120
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-2: update of the recent clinical trials.
Jeppesen PB
Gastroenterology; 2006 Feb; 130(2 Suppl 1):S127-31. PubMed ID: 16473060
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor and the short bowel syndrome.
Thompson JS
JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S113-6. PubMed ID: 10483910
[TBL] [Abstract][Full Text] [Related]
18. Rehabilitative therapy of short bowel syndrome: experimental study and clinical trial.
Li N; Zhu W; Guo F; Ren J; Li Y; Wang X; Li J
Zhonghua Wai Ke Za Zhi; 2000 Aug; 38(8):565-9. PubMed ID: 11832109
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome.
Sigalet DL; Martin GR; Butzner JD; Buret A; Meddings JB
J Pediatr Surg; 2005 May; 40(5):763-8. PubMed ID: 15937810
[TBL] [Abstract][Full Text] [Related]
20. Novel agents in the treatment of intestinal failure: humoral factors.
Yang H; Teitelbaum DH
Gastroenterology; 2006 Feb; 130(2 Suppl 1):S117-21. PubMed ID: 16473058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
